Key Points
- T. Christopher Uchida, Palomar's CFO, sold 783 shares on Feb. 18 at an average price of $128.04 for $100,255.32, leaving him with 14,752 shares — a reported 5.04% reduction in his ownership.
- Uchida has been selling multiple blocks in recent weeks (including 2,103 shares on Jan. 28, 1,326 on Jan. 29 and 545 on Jan. 31), signaling a pattern of insider disposals.
- Palomar posted strong quarterly results, with EPS of $2.24 beating the $2.06 estimate and revenue up 62.7% YoY to $492.6M, and analysts currently have a consensus "Buy" rating with a $162.17 price target.
Palomar Holdings, Inc. (NASDAQ:PLMR - Get Free Report) insider Jonathan Knutzen sold 281 shares of Palomar stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $128.04, for a total transaction of $35,979.24. Following the sale, the insider owned 27,579 shares of the company's stock, valued at approximately $3,531,215.16. The trade was a 1.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Jonathan Knutzen also recently made the following trade(s):
- On Thursday, January 29th, Jonathan Knutzen sold 444 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total transaction of $54,185.76.
- On Thursday, January 29th, Jonathan Knutzen sold 444 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total value of $54,185.76.
- On Saturday, January 31st, Jonathan Knutzen sold 290 shares of Palomar stock. The shares were sold at an average price of $121.74, for a total value of $35,304.60.
- On Wednesday, January 28th, Jonathan Knutzen sold 1,535 shares of Palomar stock. The stock was sold at an average price of $119.88, for a total value of $184,015.80.
Palomar Price Performance
NASDAQ PLMR traded down $2.81 during trading hours on Friday, reaching $120.61. 332,759 shares of the company's stock traded hands, compared to its average volume of 323,567. The firm has a market cap of $3.20 billion, a PE ratio of 16.80 and a beta of 0.44. The firm has a 50-day simple moving average of $129.40 and a 200 day simple moving average of $123.10. Palomar Holdings, Inc. has a 52-week low of $107.75 and a 52-week high of $175.85.
Palomar (NASDAQ:PLMR - Get Free Report) last issued its earnings results on Wednesday, February 11th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.06 by $0.18. The business had revenue of $492.63 million during the quarter, compared to analysts' expectations of $204.58 million. Palomar had a net margin of 22.50% and a return on equity of 22.77%. The business's revenue for the quarter was up 62.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.52 earnings per share. Sell-side analysts forecast that Palomar Holdings, Inc. will post 5.99 EPS for the current fiscal year.
Institutional Investors Weigh In On Palomar
A number of institutional investors have recently modified their holdings of the company. Allworth Financial LP boosted its holdings in Palomar by 1,970.0% in the second quarter. Allworth Financial LP now owns 207 shares of the company's stock valued at $32,000 after purchasing an additional 197 shares during the period. Salomon & Ludwin LLC acquired a new position in shares of Palomar in the 3rd quarter valued at $25,000. Richardson Financial Services Inc. boosted its stake in Palomar by 210.0% in the third quarter. Richardson Financial Services Inc. now owns 217 shares of the company's stock valued at $25,000 after acquiring an additional 147 shares in the last quarter. Geneos Wealth Management Inc. acquired a new stake in shares of Palomar in the 4th quarter valued at about $32,000. Finally, Kestra Advisory Services LLC purchased a new position in shares of Palomar during the fourth quarter worth approximately $33,000. 90.25% of the stock is owned by institutional investors and hedge funds.
Key Palomar News
Here are the key news stories impacting Palomar this week:
- Positive Sentiment: Wall Street Zen upgraded PLMR to a "Buy", adding to a string of favorable analyst notes and higher price targets from firms including Keefe, Bruyette & Woods, JPMorgan and Evercore — supporting upside vs. the consensus $162.17 target. Wall Street Zen Upgrade
- Positive Sentiment: Recent quarterly results (reported Feb. 11) showed a beat: $2.24 EPS vs. $2.06 expected and revenue of $492.6M (well above consensus), with 62.7% year-over-year revenue growth and healthy margins — fundamentals that support longer‑term earnings forecasts. Quarterly Results
- Neutral Sentiment: Institutional ownership is high (~90%); several funds adjusted positions in Q4. That concentration can reduce float and amplify moves but also means changes in institutional flows matter more than retail trading. Ownership Details
- Neutral Sentiment: Technical picture: the stock is trading below its 50-day SMA (~$129.40) and slightly below the 200-day SMA (~$123.10), signalling short-term weakness that may prompt additional selling until buyers reappear. Technicals
- Negative Sentiment: Insider selling: CFO T. Christopher Uchida sold 783 shares (about $100k) on Feb. 18, reducing his stake ~5%; President Jon Christianson and director Jonathan Knutzen also sold smaller tranches the same day. Multiple recent insider sales may be interpreted as near-term negative by market participants. Insider Selling
Wall Street Analyst Weigh In
Several research firms have recently issued reports on PLMR. Evercore began coverage on shares of Palomar in a report on Monday, February 9th. They issued an "outperform" rating and a $150.00 target price for the company. Wall Street Zen raised shares of Palomar from a "hold" rating to a "buy" rating in a research note on Saturday. JPMorgan Chase & Co. lifted their price target on Palomar from $145.00 to $155.00 and gave the company an "overweight" rating in a report on Wednesday, January 7th. Weiss Ratings raised shares of Palomar from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, January 14th. Finally, Keefe, Bruyette & Woods increased their price objective on shares of Palomar from $170.00 to $171.00 and gave the company an "outperform" rating in a research report on Tuesday, January 6th. Seven investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $162.17.
Check Out Our Latest Analysis on PLMR
Palomar Company Profile
(
Get Free Report)
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
